GIA
CELU icon

Gladstone Institutional Advisory’s Celularity CELU Stock Holding History

Gladstone Institutional Advisory’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,675
Closed -$844K – 419
2020
Q4 		$844K Sell
7,675
-2,108
-22% -$224K 0.17% 120
2020
Q3 		$1.03M Buy
+9,783
New +$1.01M 0.25% 94

Other funds holding CELU

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Gladstone Institutional Advisory's CELU Position: Q1 2021 in Review

Gladstone Institutional Advisory sold out of Celularity (CELU) in Q1 2021, closing a stake of 7,675 shares — an estimated $844K sold.

Gladstone Institutional Advisory first reported a position in CELU in Q3 2020 and held it in 2 quarters. The position peaked at $1.03M in Q3 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

  • Gladstone Institutional Advisory reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 7,675 Celularity shares in Q1 2021, an estimated $844K.
  • Gladstone Institutional Advisory first reported a position in Celularity in Q3 2020 and held it in 2 quarters.
  • Gladstone Institutional Advisory's Celularity position peaked at $1.03M in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2021, filed 17 May 2021.